DLA Piper advises on Sperco Ukraine investment
DLA Piper Ukraine has advised Europe Virgin Fund (EVF), a private equity fund, sponsored by Dragon Capital in set up of a joint venture with Ucrafarma SA.
The parties invested into Lux PHARMA Participations SA, a Luxembourg-based holding company, with Ucrafarma SA transferring various pharmaceutical assets including its 95 per cent stake in Sperco Ukraine LLC, one of the top 10 pharmaceutical manufacturers of Ukraine, and EVF providing capital for further development
DLA Piper provided full legal support to the transaction, including legal due diligence of Ukrainian and Spanish assets, drafting and negotiating transactional documents governed by English, Ukrainian and Spanish law, support of closing of the deal.
The DLA Piper team was led by legal director Illya Muchnyk under the general supervision of managing partner Margarita Karpenko. The significant input was provided by finance and projects associates Dmytro Pshenychnyuk, Maxim Andrianov, Dmytro Lapa and real estate associates — Oleg Matiusha.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
While this agreement is undoubtedly an historic diplomatic coup for the western diplomacy, the interim Geneva deal remains limited.
The tax deduction for advertising expenses has clearly become a target for Congressional tax reformers.
Analysis from The Lawyer
The Lawyer’s latest Top 50 litigation firms list shows that business for dispute specialists is roaring along while new in-depth detail reveals the winning strategies
Our list of the summer’s big deals shows how London law firms kept busy with work from Asia as well as more familiar sources